#BioLineRx #Announces #Initiation of #Phase 1/2a #Study of #GLIX1 for the #Treatment of #Glioblastoma (#GBM) tinyurl.com/5xuy7zzf $BLRX @BioLineRx_Ltd
24
Search
BioLineRx presents forward-looking financial projections during annual 2025 results conference call, emphasizing risks and uncertainties #BioLineRx #FinancialResults #FutureProjections
1
11
#BioLineRx to #Report 2025 #Annual #Results on #March 23, 2026 tinyurl.com/2jbs3whm $BLRX @BioLineRx_Ltd
23
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update $BLRX, #BioLineRx crweworld.com/article/news-p…
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update [24-November-2025] - Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral,...
From crweworld.com 41
#BioLineRx Reports Third #Quarter 2025 #Financial #Results and Provides #Corporate #Update tinyurl.com/5hmypz8h @BioLineRx_Ltd $BLRX
15
#BioLineRx to #Report #Third #Quarter 2025 #Results on #November 24, 2025 rb.gy/kfaro8 $BLRX @BioLineRx_Ltd
9
Israeli Biotech BioLineRx Secures Key U.S. Patent for GLIX1 Cancer Therapy
#BioLineRx #GLIX1
israel.com/breaking-only/…
3
#BioLineRx #Announces #Receipt of #USPTO #Notice of #Allowance for #Key #Patent #Covering #GLIX1 for #Treating a #Broad #Range of #Cancer #Types tinyurl.com/3p8kvjsv $BLRX @BioLineRx_Ltd
17
#BioLineRx Ltd. and #Hemispherian AS #Establish #Joint #Venture to #Develop GLIX1, a #First-in-#Class, #Oral, #Small #Molecule #Targeting #DNA #Damage #Response in #Glioblastoma and #Other #Cancers tinyurl.com/2f9zz3b8 $BLRX @BioLineRx_Ltd
51
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update $BLRX, #BioLineRx crweworld.com/article/news-p…
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update [14-August-2025] - Reports continued progress in the evaluation of assets for potential pipeline expansion in...
From crweworld.com 39
44
#BioLineRx to Report Second #Quarter 2025 #Results on #August 14, 2025 tinyurl.com/yc5p6dnt @BioLineRx_Ltd $BLRX
37
#BioLineRx #Announces #New #Pilot #Phase #Data from Phase 2 #Combination #Trial of #Motixafortide in #First-#Line #Pancreatic #Cancer (#PDAC) to be #Presented at #ASCO 2025 #Annual #Meeting tinyurl.com/7ut95pp9 $BLRX @BioLineRx_Ltd
1
2
160
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update $BLRX, #BioLineRx crweworld.com/article/news-p…
1
44
24
Key Date Approaching for BioLineRx Shareholders $BLRX, #BioLineRx crweworld.com/article/news-p…
1
1
1
93
#BioLineRx to #Report #First #Quarter 2025 #Results on #May 27, 2025 tinyurl.com/ymej8hp3 $BLRX @BioLineRx_Ltd
1
1
2
216
118
#BioLineRx to #Report 2024 #Annual #Results on #March 31, 2025 shorturl.at/sLuFI $BLRX @BioLineRx_Ltd
106